About Us


Prof. Dr. Antonio Colombo, FACC, FESC, FSCAI

Dr. Colombo is Director of the Cardiac Catheterization Laboratory at EMO GVM Centro Cuore Columbus and Chief of Invasive Cardiology at San Raffaele Hospital, both in Milan, Italy, and Visiting Professor of Medicine at Columbia Medical Center in New York, USA. He obtained his M.D. from University of Milan, School of Medicine. He did his medical residency in Cardiology in Milan as well as at the Cabrini Medical Center in New York and completed fellowships at the VA medical Center, Long Beach, University of California at Irvine and at St. Joseph Hospital, State University of New York in Syracuse.

Dr. Colombo has devoted his time and effort, both in the US and Europe to direct a series of Investigations to define the indications and limitations of coronary stenting. He pioneered the concept of adequate stent deployment during coronary interventions and defined the role of intravascular ultrasound in this setting. In addition, his studies along with others have redefined adequate antiplatelet therapy after coronary stenting. His investigations culminated in multiple publications in almost all prestigious journals in Cardiology in the US and in Europe. More importantly, his work had a direct impact on the techniques used by Interventional Cardiologists to treat patients with coronary artery disease all over the world.

Dr. Colombo is very active in multiple medical societies including: American College of Cardiology, American Heart Association, American College of Physicians, American College of Chest Physicians, and the American Medical Association. He is also on the Editorial Board of all major journals including Circulation, Journal of the American College of Cardiology, American Journal of Cardiovascular Drugs, Journal of Invasive Cardiology and the Italian Heart Journal.

Prof. Dr. Gregg W. Stone, FACC, FSCAI

Gregg Stone is Professor of Medicine at the Columbia University Medical Center, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital, and Co-Director of Medical Research and Education at the Cardiovascular Research Foundation in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 80 national and international multicenter randomized trials, has authored more than 2000 book chapters, manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. Gregg Stone’s areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug-eluting stents; antiplatelet and antithrombotic pharmacotherapies; transcatheter mitral valve repair and replacement; new device angioplasty including atherectomy, distal embolic protection, thrombectomy, vascular brachytherapy, and stent grafts; saphenous vein graft therapies; intravascular imaging; chronic total occlusions; left atrial appendage closure; vulnerable plaque; contrast nephropathy; clinical trial design; and regulatory issues. Gregg Stone, along with Dr. Martin B. Leon, is the director of Transcatheter Cardiovascular Therapeutics (TCT), the world’s largest symposium devoted to interventional cardiology and vascular medicine, directs the annual National Interventional Cardiology Fellow’s Course, and co-directs multiple other annual courses, including Optimizing Complex PCI Outcomes, The Left Main and Chronic Total Occlusion Summit, Bioresorbable Scaffolds: A Breakthrough PCI Technology, LAA Occlusion: A Technique Oriented Course, and Transcatheter Valve Therapies. Gregg Stone’s medical practice is devoted to interventional cardiology at New York-Presbyterian Hospital and Columbia University Medical Center.

Prof. Dr. Azfar G. Zaman, BSc, MBChB, FRCP

Azfar Zaman is Professor of Cardiology and Consultant Interventional Cardiologist at Freeman Hospital and Newcastle University, UK. Following graduation at Leeds University Medical School, he completed postgraduate training in cardiology at regional centres in Leeds, London, Cardiff and New York. He was a Fulbright Scholar and British Heart Foundation International Fellow at Mount Sinai Medical Center, New York.

Azfar Zaman is the Head of Coronary Intervention and Director of the Cardiac Catheter Laboratories in a tertiary cardiac centre performing around 3000 PCIs (800 primary PCIs) and 60 TAVIs per annum. He is the Specialty Group Lead for Cardiovascular Research in the region with an interest in clinical research and over 100 peer reviewed publications. He has a particular interest in thrombosis in diabetes and coronary artery disease and head one of the largest cardiovascular centres in the UK for clinical trials.

Prof. Dr. Adrian P Banning,  FRCP, FESC

Adrian Banning graduated from London and trained in London, Cardiff and Oxford, before becoming a Consultant Cardiologist in 1999 at the John Radcliffe in Oxford. At the forefront of the initiation of day case coronary intervention for elective patients and day case transfer for treatment for ACS patients.  Prominent in the early development of drug eluting stents particularly the Taxus series of trials where Oxford was consistently one of the very highest recruiting centres.  Top 5 recruiter in the Syntax trial and lead author on the diabetic manuscript in JACC. Second highest worldwide recruiter in the Excel trial of stents vs surgery for left main disease. Interest in treatment of left main disease/IVUS and the pathophysiology of myocardial infarction. He has presented series of live cases from oxford as the Master live operator for both TCT and PCR.
His academic interest in myocardial injury during revascularisation resulted in the awarding of the title Professor of Interventional Cardiology by Oxford University. Website: www.thecardiologist.co.uk

Prof. Dr. Malte Kelm, FESC

Malte Kelm is Professor and Chair of the Division of Cardiology, Pulmonary Diseases, and Vascular Medicine at the University Hospital Düsseldorf, Germany.

His key expertise is in the field of interventional cardiology with focus on coronary artery disease and structural heart disease. In the field of acute myocardial infarction (AMI) and ischemia/reperfusion (I/R) he has outstanding experiences. His actual scientific focus on erythrocrine functions in AMI shows that mild anemia is an independent risk factor for poor survival in patients with acute coronary syndromes.

Malte Kelm is member of the ESC guideline committee for pre-operative risk assessment, member of the expert committee of the German Research Foundation (DFG), cardiovascular research and medical technology, as well as of the national guideline committees within the German Cardiac Society. He is also member of the Editorial boards of Basic Research in Cardiology, the European Heart Journal, Clinical Research in Cardiology, Deutsche Medizinische Wochenschrift, Aktuelle Kardiologie, and the Journal of Molecular Medicine and has authored more than 300 publications published in the peer-reviewed literature with focus on myocardial ischemia & coronary artery disease, structural heart disease, and translational medicine.

Prof. Dr. Dr. Werner Mohl

Professor Werner Mohl is the innovator of the PiCSO® concept and was a long term academic surgeon at the Medical University of Vienna. Active in patient care, teaching and research in all perspectives of heart diseases including coronary hemodynamics, cardiac regeneration and cardioprotection, he also serves as advisor on a consulting basis for Miracor. He holds a medical degree and a PhD from the University of Vienna, Austria.